ELISA Kit for Heparan Sulfate Proteoglycan (HSPG)
SEA565HU
Product group Assays
Overview
- SupplierCloud-Clone Corp.
- Product NameELISA Kit for Heparan Sulfate Proteoglycan (HSPG)
- Delivery Days Customer12
- Assay Detection Range15.6-1,000pg/mL
- Assay PrecisionIntra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Heparan Sulfate Proteoglycan (HSPG) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): 3 samples with low, ...
- Assay SensitivityThe minimum detectable dose of this kit is typically less than 6.1pg/mL
- Assay SpecificityThis assay has high sensitivity and excellent specificity for detection of Heparan Sulfate Proteoglycan (HSPG). No significant cross-reactivity or interference between Heparan Sulfate Proteoglycan (HSPG) and analogues was observed.
- Assay Test PrincipleThe test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Heparan Sulfate Proteoglycan (HSPG). Standards or samples are then added to the ...
- Assay Time3h
- CertificationResearch Use Only
- UNSPSC41116158
References
- The Effect of Preoperative Methylprednisolone on Postoperative Delirium in Older Patients Undergoing Gastrointestinal Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial. Xiang XB et al., 2022 Mar 3, J Gerontol A Biol Sci Med SciRead more
- Heparin prevents in vitro glycocalyx shedding induced by plasma from COVID-19 patients. Potje SR et al., 2021 Jul 1, Life SciRead more
- Glioma targeting peptide modified apoferritin nanocage. Zhai M et al., 2018 Nov, Drug DelivRead more
- Cytotoxic and partial hepatoprotective activity of sodium ascorbate against hepatocellular carcinoma through inhibition of sulfatase-2 in vivo and in vitro. Alyoussef A et al., 2018 Jul, Biomed PharmacotherRead more
- Circulating syndecans during critical illness. Nelson A et al., 2017 May, APMISRead more
- Endothelial glycocalyx layer shedding following lung resection. Arthur A et al., 2016 Oct, Biomark MedRead more
- Impairment of the endothelial glycocalyx in cardiogenic shock and its prognostic relevance. Jung C et al., 2015 May, ShockRead more
- Evaluation of antiglypican-3 therapy as a promising target for amelioration of hepatic tissue damage in hepatocellular carcinoma. Zaghloul RA et al., 2015 Jan 5, Eur J PharmacolRead more
- Fibrinogen, an endogenous ligand of Toll-like receptor 4, activates monocytes in pre-eclamptic patients. Al-ofi E et al., 2014 Jun, J Reprod ImmunolRead more
- Suramin inhibits hepatic tissue damage in hepatocellular carcinoma through deactivation of heparanase enzyme. Tayel A et al., 2014 Apr 5, Eur J PharmacolRead more